Our study reveals an important underlying mechanism of celecoxib-mediated inhibition of glioblastoma cell growth, by induction of DNA damage leading to p53-dependent G1 cell cycle arrest and autophagy, but not apoptosis. The gene discussed is TP53; the disease is glioblastoma.